Evidence map›Paper›PMID 39970201›Full record

ArticleScience advances2025

Deep profiling of B cells responding to various pathogens uncovers compartments in IgG memory B cell and antibody-secreting lineages.

Mathieu Claireaux, George Elias, Gius Kerster, Lisan H Kuijper, Mariël C Duurland, Alberta G A Paul, Judith A Burger, Meliawati Poniman, Wouter Olijhoek, Nina de Jong and 14 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Targeting T follicular helper cells for lifelong health.Nature reviews. Drug discovery · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Mathieu ClaireauxDepartment of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0003-1890-9493
George EliasDepartment of Immunopathology, Sanquin Research and Landsteiner Laboratory, University of Amsterdam, Amsterdam, Netherlands.
Gius KersterDepartment of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0001-6880-7351
Lisan H KuijperAmsterdam Institute for Immunology and Infectious diseases, Amsterdam, Netherlands.
Mariël C DuurlandAmsterdam Institute for Immunology and Infectious diseases, Amsterdam, Netherlands.
Alberta G A PaulApplication Department, Cytek Biosciences Inc., Fremont, CA, USA.ORCID 0000-0002-9318-3760
Judith A BurgerDepartment of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Meliawati PonimanDepartment of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0001-8390-2058
Wouter OlijhoekDepartment of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0003-1651-3954
Nina de JongAmsterdam Institute for Immunology and Infectious diseases, Amsterdam, Netherlands.
Rivka de JonghAmsterdam Institute for Immunology and Infectious diseases, Amsterdam, Netherlands.ORCID 0009-0005-2595-3304
Elke WynbergDepartment of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0002-8245-086X
Hugo D G van WilligenDepartment of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0002-4567-3132
Maria PrinsAmsterdam Institute for Immunology and Infectious diseases, Amsterdam, Netherlands.ORCID 0000-0003-2967-0289
Godelieve J De BreeAmsterdam Institute for Immunology and Infectious diseases, Amsterdam, Netherlands.
Menno D de JongDepartment of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Taco W KuijpersAmsterdam Institute for Immunology and Infectious diseases, Amsterdam, Netherlands.ORCID 0000-0002-7421-3370
Filip EftimovAmsterdam Institute for Immunology and Infectious diseases, Amsterdam, Netherlands.
C Ellen van der SchootAmsterdam Institute for Immunology and Infectious diseases, Amsterdam, Netherlands.ORCID 0000-0002-8065-3540
Theo RispensAmsterdam Institute for Immunology and Infectious diseases, Amsterdam, Netherlands.ORCID 0000-0001-9600-1312
Juan J Garcia-VallejoAmsterdam Institute for Immunology and Infectious diseases, Amsterdam, Netherlands.
Anja Ten BrinkeAmsterdam Institute for Immunology and Infectious diseases, Amsterdam, Netherlands.ORCID 0000-0002-0135-7496
Marit J van GilsDepartment of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
S Marieke van HamAmsterdam Institute for Immunology and Infectious diseases, Amsterdam, Netherlands.ORCID 0000-0003-1999-9494

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Improving our understanding of B cell transition to memory B cells (MBCs) and antibody-secreting cells (ASCs) is crucial for clinical monitoring and vaccine strategies. To explore these dynamics, we compared prepandemic antigen responses (influenza hemagglutinin, respiratory syncytial virus fusion glycoprotein, and tetanus toxoid) with recently encountered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen responses in convalescent COVID-19 patients using spectral flow cytometry. Our analysis revealed the CD43+CD71+IgG+ activated B cell subset, highly enriched for SARS-CoV-2 specificities, as a juncture for ASC and MBC differentiation, with CD86+ phenotypically similar to ASCs and CD86- to IgG+ MBCs. Moreover, subpopulations within IgG+ MBCs were further identified based on CD73 and CD24 expression. Activated MBCs (CD73-/CD24lo) were predominantly SARS-CoV-2-specific, while resting MBCs (CD73+/CD24hi) recognized prepandemic antigens. A CD95- subcluster within resting MBCs accounted for over 40% of prepandemic-specific cells, indicating long-lasting memory. These findings advance our understanding of IgG+ MBC and ASC development stages, shedding light on the decision-making process guiding their differentiation.

Indexed as

Antibody-Producing CellsB-LymphocytesCOVID-19Immunoglobulin GImmunologic MemoryMemory B CellsSARS-CoV-2AdultAntibodies, ViralCell LineageFemaleHumansMaleMiddle AgedAntibodies, ViralImmunoglobulin G

Identifiers

PMID39970201
PMCPMC11837990

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.